CLL NGS PANEL (FISH+KT)+IGHV & TP53 MUTATION ANALYSIS (SDL10877)

This panel combines FISH, karyotyping, IGHV, and TP53 analysis for CLL. Results stratify risk, guiding targeted therapies like BTK inhibitors for high-risk chronic lymphocytic leukemia.